(SOLB) Solvay - BR
Sector: Basic Materials | Industry: Chemicals | Exchange: BR (Belgium) | Market Cap: 2.746m EUR | Total Return: -2.2% in 12m
Avg Turnover: 7.81M
EPS Trend: -92.8%
Qual. Beats: 1
Rev. Trend: -91.4%
Qual. Beats: 2
Warnings
Volatile
Tailwinds
No distinct edge detected
Solvay SA is a Belgium-based chemical manufacturer specializing in essential and performance chemistries. Its portfolio centers on the production of soda ash, hydrogen peroxide, precipitated silica, and rare-earth formulations. These materials serve critical industrial functions in glass manufacturing, lithium-ion battery production, water treatment, and semiconductor fabrication.
The company operates within the diversified chemicals sub-industry, where profitability is often tied to energy costs and global manufacturing demand. Solvay’s business model relies on large-scale production efficiency and a vertically integrated supply chain for raw materials like sodium carbonate, which is essential for the transition to solar energy and electric vehicle infrastructure.
Investors can further analyze the companys valuation metrics and historical performance data on ValueRay.
- Soda ash demand and pricing volatility in glass and detergent markets
- Energy costs and carbon taxes impact European chemical manufacturing margins
- Global solar panel production drives demand for sodium carbonate and peroxide
- Silica volume growth tied to fuel-efficient tire adoption and automotive recovery
| Net Income: -26.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.20 > 1.0 |
| NWC/Revenue: 8.70% < 20% (prev 12.86%; Δ -4.17% < -1%) |
| CFO/TA 0.10 > 3% & CFO 611.0m > Net Income -26.0m |
| Net Debt (2.09b) to EBITDA (663.0m): 3.15 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.1m) vs 12m ago -0.48% < -2% |
| Gross Margin: 21.90% > 18% (prev 21.85%; Δ 0.05% > 0.5%) |
| Asset Turnover: 74.05% > 50% (prev 80.0%; Δ -5.95% > 0%) |
| Interest Coverage Ratio: 2.11 > 6 (EBIT TTM 259.0m / Interest Expense TTM 123.0m) |
| A: 0.07 (Total Current Assets 2.19b - Total Current Liabilities 1.79b) / Total Assets 6.20b |
| B: 0.24 (Retained Earnings 1.49b / Total Assets 6.20b) |
| C: 0.04 (EBIT TTM 259.0m / Avg Total Assets 6.27b) |
| D: 0.22 (Book Value of Equity 1.12b / Total Liabilities 5.02b) |
| Altman-Z'' = 1.72 = BBB |
| DSRI: 0.98 (Receivables 1.08b/1.21b, Revenue 4.64b/5.08b) |
| GMI: 1.00 (GM 21.85% / 21.90%) |
| AQI: 1.14 (AQ_t 0.27 / AQ_t-1 0.24) |
| SGI: 0.91 (Revenue 4.64b / 5.08b) |
| TATA: -0.10 (NI -26.0m - CFO 611.0m) / TA 6.20b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of June 15, 2026, the stock is trading at EUR 26.80 with a total of 343,530 shares traded.
Over the past week, the price has changed by +2.21%,
over one month by +3.96%,
over three months by +7.91% and
over the past year by -2.15%.
Solvay has no consensus analysts rating.
P/E Forward = 10.7875
P/S = 0.5911
P/B = 2.4547
P/EG = 0.2896
Revenue TTM = 4.64b EUR
EBIT TTM = 259.0m EUR
EBITDA TTM = 663.0m EUR
Long Term Debt = 1.83b EUR (from longTermDebt, last quarter)
Short Term Debt = 366.0m EUR (from shortTermDebt, last quarter)
Debt = 2.58b EUR (from shortLongTermDebtTotal, last quarter) + Leases 379.0m
Net Debt = 2.09b EUR (calculated: Debt 2.58b - CCE 486.0m)
Enterprise Value = 4.83b EUR (2.75b + Debt 2.58b - CCE 486.0m)
Interest Coverage Ratio = 2.11 (Ebit TTM 259.0m / Interest Expense TTM 123.0m)
EV/FCF = 11.62x (Enterprise Value 4.83b / FCF TTM 416.0m)
FCF Yield = 8.60% (FCF TTM 416.0m / Enterprise Value 4.83b)
FCF Margin = 8.96% (FCF TTM 416.0m / Revenue TTM 4.64b)
Net Margin = -0.56% (Net Income TTM -26.0m / Revenue TTM 4.64b)
Gross Margin = 21.90% ((Revenue TTM 4.64b - Cost of Revenue TTM 3.63b) / Revenue TTM)
Gross Margin QoQ = 23.29% (prev 21.39%)
Tobins Q-Ratio = 0.78 (Enterprise Value 4.83b / Total Assets 6.20b)
Interest Expense / Debt = 4.78% (Interest Expense 123.0m / Debt 2.58b)
Taxrate = 35.71% (15.0m / 42.0m)
NOPAT = 166.5m (EBIT 259.0m * (1 - 35.71%))
Current Ratio = 1.23 (Total Current Assets 2.19b / Total Current Liabilities 1.79b)
Debt / Equity = 2.31 (Debt 2.58b / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = 3.15 (Net Debt 2.09b / EBITDA 663.0m)
Debt / FCF = 5.02 (Net Debt 2.09b / FCF TTM 416.0m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.41% (Net Income -26.0m / Total Assets 6.20b)
RoE = -2.32% (Net Income TTM -26.0m / Total Stockholder Equity 1.12b)
RoCE = 8.78% (EBIT 259.0m / Capital Employed (Equity 1.12b + L.T.Debt 1.83b))
RoIC = 3.66% (NOPAT 166.5m / Invested Capital 4.55b)
WACC = 4.51% (E(2.75b)/V(5.32b) * Re(5.86%) + D(2.58b)/V(5.32b) * Rd(4.78%) * (1-Tc(0.36)))
Discount Rate = 5.86% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -33.33 | Cagr: -0.07%
[DCF] Terminal Value 77.97% ; FCFF base≈364.0m ; Y1≈417.3m ; Y5≈614.1m
[DCF] Fair Price = 68.46 (EV 9.24b - Net Debt 2.09b = Equity 7.15b / Shares 104.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -92.83 | EPS CAGR: -49.87% | SUE: 0.84 | # QB: 1
Revenue Correlation: -91.43 | Revenue CAGR: -36.85% | SUE: 4.0 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.47 | Chg30d=-37.77% | Revisions=-20% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.47 | Chg30d=+14.63% | Revisions=+20% | Analysts=2
EPS current Year (2026-12-31): EPS=2.31 | Chg30d=-0.61% | Revisions=-62% | GrowthEPS=-18.6% | GrowthRev=-3.5%
EPS next Year (2027-12-31): EPS=2.60 | Chg30d=-5.87% | Revisions=-50% | GrowthEPS=+12.2% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: -62%